欧洲前列腺癌诊断市场 – 行业趋势和 2028 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Medical Devices Europe Prostate Cancer Diagnostics Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲前列腺癌诊断市场 – 行业趋势和 2028 年预测

  • Medical Devices
  • Published Report
  • Mar 2021
  • Europe
  • 350 页面
  • 桌子數： 193
  • 图号： 55
立即购买 立即购买

Europe Prostate Cancer Diagnostics Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 2021 –2028
Diagram Market Size (Base Year)
 USD 636.30 Million
Diagram Market Size (Forecast Year)
 USD 1,604.78 Million
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>欧洲前列腺癌诊断药物市场，按产品类型（仪器、试剂、耗材及配件）、诊断类型（初步筛选试验、确认试验）、年龄组（成人、儿童和老年病学）、类型（前列腺腺癌、小细胞癌等）、分期（局限性前列腺癌、复发性/晚期前列腺癌和去势抵抗性前列腺癌（转移性和非转移性）、样品类型（血液、组织、尿液等）、最终用户（独立诊断实验室、医院、癌症研究机构、诊所、门诊手术中心等）、分销渠道（直接招标和零售销售）、国家（德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、荷兰、瑞士、比利时和欧洲其他地区）行业趋势及预测至 2028 年

欧洲前列腺癌诊断市场市场分析与洞察：欧洲前列腺癌诊断市场

前列腺癌诊断市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 12.5%，预计将从 2020 年的 6.363 亿美元增至 2028 年的 16.0478 亿美元。对疾病负担的关注度不断提高和对疾病的认识不断提高是预测期内推动市场发展的主要驱动力。

诊断需要使用仪器、试剂、耗材和配件。PSA 检测、直肠指检、MRI、PET/CT 扫描等是前列腺癌诊断中使用的一些初步和确认性检测。前列腺癌患病率的上升、前列腺癌诊断研究和开发的增加、老年人口的增加、前列腺癌诊断新产品的推出预计将推动前列腺癌诊断市场的增长。此外，新兴企业的投资和资金增加、前列腺癌诊断的报销政策以及政府针对癌症诊断的举措都促进了前列腺癌诊断市场的增长。

发达国家和发展中国家对前列腺癌诊断的需求都在增加，其背后的原因是人们对前列腺癌死亡率的关注度不断提高。由于创新产品的推出、意识的提高和各种政府举措，前列腺癌诊断市场正在增长。由于新兴市场的探索、市场参与者的战略举措以及对头发问题的认识不断提高，市场将在预测期内增长。

前列腺癌诊断市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预​​期目标。

欧洲前列腺癌诊断市场欧洲前列腺癌诊断市场范围和市场规模

根据产品类型、诊断类型、年龄组、类型、阶段、样本类型、最终用户和分销渠道，前列腺癌诊断市场分为八个显著的部分。

  • 根据产品类型，前列腺癌诊断市场细分为仪器、试剂和耗材以及配件。2021 年，试剂和耗材细分市场在前列腺癌诊断市场中占据主导地位，因为它包括 PSA 检测产品，这是初步检测推荐的主要检测。PSA 测量前列腺细胞产生的蛋白质，这是前列腺癌的第一线诊断。
  • 根据诊断类型，前列腺癌诊断市场分为初步筛查测试和确认测试。2021 年，初步筛查测试部分在前列腺癌诊断市场中占据主导地位，因为初步测试的数量远远超过确认测试的数量。
  • 根据年龄组，前列腺癌诊断市场分为成人、儿童和老年病。2021 年，老年病学在前列腺癌诊断市场中占据主导地位，因为约 60% 的病例是在 65 岁以上的男性中诊断出来的。前列腺癌诊断的平均年龄为 66 岁。这种疾病很少发生在 40 岁以下的人身上。黑人男性中诊断出的新病例数量比白人男性中诊断出的新病例数量高出 60%。
  • 根据类型，前列腺癌诊断市场分为前列腺腺癌、小细胞癌和其他。2021 年，前列腺腺癌细分市场在前列腺癌诊断市场中占据主导地位，因为超过 95% 的前列腺癌是腺癌，发生在前列腺的腺细胞和腺管中。几乎所有患有前列腺癌的男性都属于这种类型。它是男性癌症相关死亡的第二大原因。一旦癌症发展到一定阶段，异常细胞就会扩散到身体的其他部位，从而导致转移，从而占据市场主导地位。
  • 根据分期，前列腺癌诊断市场分为局限性前列腺癌、复发性/晚期前列腺癌和去势抵抗性前列腺癌（转移性和非转移性）。2021 年，局限性前列腺癌占据前列腺癌诊断市场的主导地位，因为大约 80% 至 85% 的前列腺癌是在局部或区域阶段发现的，代表 I、II 和 III 期。大多数在局部或区域阶段被诊断和治疗的男性将在五年后无病生存。这种类型的癌症不会扩散到任何附近的组织或身体的远处部位。局限性前列腺癌的分期为 1 期和 2 期。低风险局限性前列腺癌的肿瘤生长缓慢。
  • 根据样本类型，前列腺癌诊断市场分为血液、组织、尿液和其他。2021 年，血液部分将主导前列腺癌诊断市场，因为血液是最常见的初步测试（即 PSA 测试）的主要样本，而且由于血液容易获得，血液样本采集程序不太复杂，不需要太多时间，预计这将主导前列腺癌诊断市场。
  • 根据最终用户，前列腺癌诊断市场细分为独立诊断实验室、医院、癌症研究机构、诊所、门诊手术中心等。2021 年，独立诊断实验室细分市场在前列腺癌诊断市场占据主导地位，因为该细分市场专门从事各种前列腺癌诊断。此外，独立诊断实验室能够在安全的医疗环境中提供稳健、准时、经济高效和高质量的诊断护理和服务，并且方便咨询医生/医疗机构将批量诊断测试外包给独立诊断实验室，以提供更好的客户服务。
  • 根据分销类型，前列腺癌诊断市场分为直接招标和零售。2021 年，直接招标部分在前列腺癌诊断市场占据主导地位，因为它们是医疗机构和诊断实验室采购试剂、耗材、设备和配件的主要来源。随着医疗成本的增加，医疗服务提供商正专注于为客户提供更好的服务，同时降低总体成本。通过直接招标采购产品对医疗保健提供商来说具有很高的成本效益。

前列腺癌诊断市场国家层面分析

根据产品类型、诊断类型、年龄组、类型、阶段、样本类型、最终用户和分销渠道，前列腺癌诊断市场分为八个显著的部分。

前列腺癌诊断市场报告涵盖的国家包括德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、荷兰、瑞士、比利时和欧洲其他地区。

由于前列腺癌患病率不断上升且报销前景良好，预计欧洲将在预测期内以最高复合年增长率增长。由于老年人口不断增加，预计德国将在欧洲市场占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。  

制造商的战略举措为前列腺癌诊断市场参与者创造新机遇 

前列腺癌诊断市场还为您提供了每个国家前列腺癌诊断产品销售增长、前列腺癌诊断技术进步的影响以及监管环境变化对前列腺癌诊断市场的支持的详细市场分析。数据涵盖 2011 年至 2019 年的历史时期。

竞争格局和前​​列腺癌诊断市场份额分析

前列腺癌诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对前列腺癌诊断市场的关注有关。

提供前列腺癌诊断的主要公司包括 F. Hoffmann-La Roche Ltd、Siemens Healthcare GmbH、OPKO Health Inc.、Abott、Beckman Coulter, Inc.（丹纳赫的子公司）以及其他国内和全球公司。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。

全球各地的许多公司也发起了许多产品的发布和协议，这也加速了前列腺癌诊断市场的发展。

例如，  

  • 2020 年 12 月，Fujirebio Europe 宣布他们已获得法兰德斯创新与创业 (VLAIO) 的 87.6 万美元资助，用于开发结合第三代测序 (TGS) 技术的临床体外诊断 (IVD) 平台。此举旨在开发具有成本效益、准确且便携的 IVD。这将提升公司形象，并增加公司的研发。

市场参与者的合作、合资和其他策略正在增强公司在前列腺癌诊断市场中的市场，这也为组织改善其在前列腺癌诊断市场中的产品提供了好处。

 

 

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE PROSTATE CANCER DIAGNOSTICS MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. product type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET end users coverage GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Epidemiology
  5. COMPARATIVE ANALYSIS WITH PARENT MARKET
  6. REGULATORY FRAMEWORK: EUROPE PROSTATE CANCER DIAGNOSTICS MARKET
    1. REGULATORY SCENARIO IN EUROPEAN UNION
  7. market overview
    1. drivers
      1. INCREASING PREVALENCE OF PROSTATE CANCER
      2. INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
      3. INCREASE IN GERIATRIC POPULATION
      4. LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
      5. DISEASE CAUSING PROSTATE CANCER
    2. RESTRAINTS
      1. CONTROVERSY RELATED TO PSA TESTING
      2. HIGH COST OF DIAGNOSTICS PROCEDURE
      3. LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    3. OPPORTUNITIES
      1. RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
      2. REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
      3. GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS
      4. RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
    4. Challenges
      1. STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
      2. OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
      3. INACCURATE DIAGNOSIS RESULTS
  8. IMPACT OF COVID-19 ON EUROPE PROSTATE CANCER DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
    5. KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
    6. CONCLUSION
  9. Europe prostate cancer diagnostics market, BY product type
    1. overview
    2. reagents & consumables
    3. instruments
    4. accessories
  10. Europe prostate cancer diagnostics market, BY DIAGNOSTICS TYPE
    1. overview
    2. preliminary screening tests
      1. Prostate-Specific Antigen (PSA) Test
      2. Digital Rectal Exam (DRE) Test
    3. Confirmatory Tests
      1. PCA3 Test
      2. biopsy
      3. imaging tests
        1. ULTRASOUND
        2. MAGNETIC RESONANCE IMAGING (MRI)
          1. MULTIPARAMETRIC MRI
          2. MRI FUSION-GUIDED PROSTATE BIOPSY
        3. CT SCAN
        4. BONE SCAN
        5. PET/CT SCAN
      4. biomarker
        1. RNA BIOMARKERS
        2. DNA BIOMARKERS
        3. PROTEIN BIOMARKERS
  11. Europe prostate cancer diagnostics market, By type
    1. overview
    2. PROSTATIC ADENOCARCINOMA
    3. small cell carcinoma
    4. Others
  12. Europe prostate cancer diagnostics market, BY AGE GROUP
    1. overview
    2. geriatrics
    3. adult
    4. Pediatric
  13. Europe prostate cancer diagnostics market, BY Stage
    1. overview
    2. LOCALIZED PROSTATE CANCER
    3. RECURRENT/ADVANCED PROSTATE CANCER
    4. CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
  14. Europe prostate cancer diagnostics market, BY sample type
    1. overview
    2. Blood
    3. tissue
    4. urine
    5. others
  15. Europe prostate cancer diagnostics market, BY end users
    1. overview
    2. Independent Diagnostic Laboratories
    3. hospitals
    4. Clinics
    5. Ambulatory Surgical Centers
    6. Cancer Research Institutes
    7. others
  16. Europe prostate cancer diagnostics market, BY Distribution Channel
    1. overview
    2. direct tender
    3. retail sales
  17. Europe prostate cancer diagnostics market, BY Country
    1. GERMANY
    2. FRANCE
    3. u.k.
    4. iTALY
    5. SPAIN
    6. RUSSIA
    7. SWITZERLAND
    8. NETHERLANDS
    9. TURKEY
    10. bELGIUM
    11. REST OF EUROPE
  18. EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY landscape
    1. company share analysis: europe
  19. SWOT
  20. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHot
      2. REVENUE ANALYSIS
      3. product Portfoli0
      4. RECENT DEVELOPMENTs
    2. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. siemens HEALTHCARE gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. OPko HEALTH INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Beckman Coulter, Inc. (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. acon laboratories inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. Biomerieux sa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    8. Diasorin s.p.a
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLI0
      4. RECENT DEVELOPMENTS
    9. Eurolyser Diagnostica GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    10. FUJIREBIO
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI
      3. RECENT DEVELOPMENTS
    11. GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. HOLOGIC, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. MDXHEALTHCARE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. Myraid genetics, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    15. Prostatype Genomics
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. PROTEOMEDIX
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  21. questionnaire
  22. related reports

表格列表

TABLE 1 AGE AND PROBABILITY OF DEVELOPING PROSTATE CANCER

TABLE 2 Europe prostate cancer diagnostics market, By product type, 2019-2028 (USD Million)

TABLE 3 Europe prostate cancer diagnostics market, By product type, 2019-2028 (UNits)

TABLE 4 Europe prostate cancer diagnostics market, By DIAGNOSTICS TYPE, 2019-2028 (USD Million)

TABLE 5 EUROPE preliminary screening tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 6 EUROPE Confirmatory tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 7 EUROPE imaging tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 8 EUROPE Magnetic Resonance Imaging (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 9 EUROPE biomarker IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)

TABLE 10 Europe prostate cancer diagnostics market, By type, 2019-2028 (USD million)

TABLE 11 Europe prostate cancer diagnostics market, By age group, 2019-2028 (USD Million)

TABLE 12 Europe prostate cancer diagnostics market, By Stage, 2019-2028 (USD Million)

TABLE 13 Europe prostate cancer diagnostics market, By Sample Type, 2019-2028 (USD Million)

TABLE 14 Europe prostate cancer diagnostics market, By End Users, 2019-2028 (USD Million)

TABLE 15 Europe prostate cancer diagnostics market, By distribution channel, 2019-2028 (USD Million)

TABLE 16 Europe prostate cancer diagnostics market, By country, 2019-2028 (USD Million)

TABLE 17 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 18 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 19 GERMANY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 20 GERMANY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 21 GERMANY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 22 GERMANY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 23 GERMANY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 24 GERMANY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 25 GERMANY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 26 GERMANY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 27 GERMANY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 28 GERMANY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 29 GERMANY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 30 GERMANY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 31 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 32 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 33 FRANCE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 34 FRANCE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 35 FRANCE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 36 FRANCE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 37 FRANCE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 38 FRANCE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 39 FRANCE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 40 FRANCE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 41 FRANCE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 42 FRANCE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 43 FRANCE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 44 FRANCE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 45 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 46 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 47 U.K. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 48 U.K. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 49 U.K. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 50 U.K. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 51 U.K. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 52 U.K. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 53 U.K. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 54 U.K. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 55 U.K. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 56 U.K. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 57 U.K. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 58 U.K. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 59 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 60 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 61 ITALY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 62 ITALY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 63 ITALY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 64 ITALY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 65 ITALY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 66 ITALY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 67 ITALY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 68 ITALY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 69 ITALY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 70 ITALY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 71 ITALY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 72 ITALY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 73 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 74 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 75 SPAIN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 76 SPAIN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 77 SPAIN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 78 SPAIN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 79 SPAIN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 80 SPAIN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 81 SPAIN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 82 SPAIN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 83 SPAIN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 84 SPAIN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 85 SPAIN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 86 SPAIN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 87 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 88 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 89 RUSSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 90 RUSSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 91 RUSSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 92 RUSSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 93 RUSSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 94 RUSSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 95 RUSSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 96 RUSSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 97 RUSSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 98 RUSSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 99 RUSSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 100 RUSSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 101 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 102 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 103 SWITZERLAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 104 SWITZERLAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 105 SWITZERLAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 106 SWITZERLAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 107 SWITZERLAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 108 SWITZERLAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 109 SWITZERLAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 110 SWITZERLAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 111 SWITZERLAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 112 SWITZERLAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 113 SWITZERLAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 114 SWITZERLAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 115 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 116 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 117 NETHERLANDS Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 118 NETHERLANDS Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 119 NETHERLANDS Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 120 NETHERLANDS Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 121 NETHERLANDS Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 122 NETHERLANDS Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 123 NETHERLANDS Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 124 NETHERLANDS Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 125 NETHERLANDS Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 126 NETHERLANDS Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 127 NETHERLANDS Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 128 NETHERLANDS Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 129 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 130 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 131 TURKEY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 132 TURKEY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 133 TURKEY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 134 TURKEY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 135 TURKEY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 136 TURKEY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 137 TURKEY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 138 TURKEY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 139 TURKEY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 140 TURKEY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 141 TURKEY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 142 TURKEY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 143 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 144 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 145 BELGIUM Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 146 BELGIUM Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 147 BELGIUM Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 148 BELGIUM Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 149 BELGIUM Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 150 BELGIUM Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 151 BELGIUM Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 152 BELGIUM Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 153 BELGIUM Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 154 BELGIUM Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 155 BELGIUM Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 156 BELGIUM Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 157 rest of Europe prostate cancer diagnostics market, By Product Type, 2019-2028 (USD Million)

图片列表

FIGURE 1 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: segmentation

FIGURE 2 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: data triangulation

FIGURE 3 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: regional VS country MARKET ANALYSIS

FIGURE 5 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: MARKET end users coverage GRID

FIGURE 10 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 12 INCREASING PREVALENCE OF PROSTATE CANCER and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE EUROPE PROSTATE CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the EUROPE PROSTATE CANCER DIAGNOSTICS MARKETin 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE PROSTATE CANCER DIAGNOSTICS MARKET

FIGURE 15 GERIATRIC POPULATION IN THE EUROPEAN REGION

FIGURE 16 Europe prostate cancer diagnostics market : BY product type, 2020

FIGURE 17 Europe prostate cancer diagnostics market : BY product type, 2021-2028 (USD Million)

FIGURE 18 Europe prostate cancer diagnostics market : BY product type, CAGR (2021-2028)

FIGURE 19 PROSTATE CANCER DIAGNOSTICS market : BY product type, LIFELINE CURVE

FIGURE 20 Europe prostate cancer diagnostics market : BY DIAGNOSTICS TYPE, 2020

FIGURE 21 Europe prostate cancer diagnostics market : BY DIAGNOSTICS TYPE 2021-2028 (USD Million)

FIGURE 22 Europe prostate cancer diagnostics market : BY DIAGNOSTICS TYPE, CAGR (2021-2028)

FIGURE 23 Europe prostate cancer diagnostics market : BY DIAGNOSTICS TYPE, LIFELINE CURVE

FIGURE 24 Europe prostate cancer diagnostics market : By type, 2020

FIGURE 25 Europe prostate cancer diagnostics market : By type, 2021-2028 (USD Million)

FIGURE 26 Europe prostate cancer diagnostics market : By type, CAGR (2021-2028)

FIGURE 27 Europe prostate cancer diagnostics market : By type, LIFELINE CURVE

FIGURE 28 Europe prostate cancer diagnostics market : BY age group, 2020

FIGURE 29 Europe prostate cancer diagnostics market : BY age group, 2021-2028 (USD Million)

FIGURE 30 Europe prostate cancer diagnostics market : BY age group, CAGR (2021-2028)

FIGURE 31 Europe prostate cancer diagnostics market : BY age group, LIFELINE CURVE

FIGURE 32 Europe prostate cancer diagnostics market : BY stage, 2020

FIGURE 33 Europe prostate cancer diagnostics market : BY stage, 2021-2028 (USD Million)

FIGURE 34 Europe prostate cancer diagnostics market : BY stage, CAGR (2021-2028)

FIGURE 35 Europe prostate cancer diagnostics market : BY stage, LIFELINE CURVE

FIGURE 36 Europe prostate cancer diagnostics market : BY sample type, 2020

FIGURE 37 Europe prostate cancer diagnostics market : BY sample type, 2021-2028 (USD Million)

FIGURE 38 Europe prostate cancer diagnostics market : BY sample type, CAGR (2021-2028)

FIGURE 39 Europe prostate cancer diagnostics market : BY sample type, LIFELINE CURVE

FIGURE 40 Europe prostate cancer diagnostics market : BY end users, 2020

FIGURE 41 Europe prostate cancer diagnostics market : BY end users, 2021-2028 (USD Million)

FIGURE 42 Europe prostate cancer diagnostics market : BY end users, CAGR (2021-2028)

FIGURE 43 Europe prostate cancer diagnostics market : BY end users, LIFELINE CURVE

FIGURE 44 Europe prostate cancer diagnostics market : BY distribution channel, 2020

FIGURE 45 Europe prostate cancer diagnostics market : BY distribution channel, 2021-2028 (USD Million)

FIGURE 46 Europe prostate cancer diagnostics market : BY distribution channel, CAGR (2021-2028)

FIGURE 47 Europe prostate cancer diagnostics market : BY distribution, LIFELINE CURVE

FIGURE 48 Europe prostate cancer diagnostics market : SNAPSHOT (2020)

FIGURE 49 Europe prostate cancer diagnostics market : BY COUNTRY (2020)

FIGURE 50 Europe prostate cancer diagnostics market : BY COUNTRY (2021 & 2028)

FIGURE 51 Europe prostate cancer diagnostics market : BY COUNTRY (2020 & 2028)

FIGURE 52 Europe prostate cancer diagnostics market : BY Product type (2021-2028)

FIGURE 53 europe Prostate cancer diagnostics market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Europe Prostate Cancer Diagnostics Market is projected to grow at a CAGR of 4.5% during the forecast period by 2028.
The future market value of the Europe Prostate Cancer Diagnostics Market is expected to reach USD 1,689,861.89 thousand by 2028.
The major players in the Europe prostate cancer diagnostics market are F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, OPKO Health Inc., Abott, Beckman Coulter, Inc. (A Subsidiary of Danaher), among other domestic and global players.
The countries covered in the Europe prostate cancer diagnostics market are Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Belgium and Rest of Europe.

浏览相关页面

Banner